{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T07:01:47Z","timestamp":1762326107807,"version":"3.37.0"},"reference-count":41,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MBE"],"published-print":{"date-parts":[[2023]]},"DOI":"10.3934\/mbe.2023783","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T01:37:12Z","timestamp":1739237832000},"page":"17625-17645","source":"Crossref","is-referenced-by-count":1,"title":["Predicting response to combination evofosfamide and immunotherapy under hypoxic conditions in murine models of colon cancer"],"prefix":"10.3934","volume":"20","author":[{"given":"Ernesto A. B. F.","family":"Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Oden Institute for Computational Engineering and Sciences, The University of Texas at Austin, 201 East 24th St, Austin, TX 78712, USA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick N.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Larimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna G.","family":"Sorace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Yankeelov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Texas Advanced Computing Center, The University of Texas at Austin, 10100 Burnet Rd (R8700), Austin, TX 78758, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Radiology, The University of Alabama at Birmingham, 619 19th St S, Birmingham, AL 35294, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Graduate Biomedical Sciences, The University of Alabama at Birmingham, 1075 13th St S, Birmingham, AL 35294, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, 1824 6th Ave S, Birmingham, AL 35233, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Biomedical Engineering, The University of Alabama at Birmingham, 1075 13th St S, Birmingham, AL 35294, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Biomedical Engineering, The University of Texas at Austin, 1107 W. Dean Keeton St, Austin, TX 78712, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Diagnostic Medicine, The University of Texas at Austin, 1601 Trinity St Bldg B, Austin, TX 78712, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Oncology, The University of Texas at Austin, 1601 Trinity St Bldg B, Austin, TX 78712, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, 623 W. 38th St Ste 300, Austin, TX 78705, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, 1400 Pressler St Unit 1472, Houston, TX 77030, USA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2321","reference":[{"key":"key-10.3934\/mbe.2023783-1","doi-asserted-by":"publisher","unstructured":"D. Hanahan, Hallmarks of Cancer: New Dimensions, <i>Cancer Discov.<\/i>, <b>12<\/b> (2022), 31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"key-10.3934\/mbe.2023783-2","doi-asserted-by":"publisher","unstructured":"I. N. Fleming, R. Manavaki, P. J. Blower, C. West, K. J. Williams, A. L. Harris, et al., Imaging tumour hypoxia with positron emission tomography, <i>Br. J. Cancer<\/i>, <b>112<\/b> (2015), 238\u2013250. https:\/\/doi.org\/10.1038\/bjc.2014.610","DOI":"10.1038\/bjc.2014.610"},{"key":"key-10.3934\/mbe.2023783-3","doi-asserted-by":"publisher","unstructured":"B. Muz, P. de la Puente, F. D. Azab, A. K. Azab, The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy, <i>Hypoxia<\/i>, <b>3<\/b> (2015), 83\u201392. https:\/\/doi.org\/10.2147\/HP.S93413","DOI":"10.2147\/HP.S93413"},{"key":"key-10.3934\/mbe.2023783-4","doi-asserted-by":"publisher","unstructured":"P. Vaupel, A. Mayer, Hypoxia in cancer: Significance and impact on clinical outcome, <i>Cancer Metastasis Rev.<\/i>, <b>26<\/b> (2007), 225\u2013239. https:\/\/doi.org\/10.1007\/s10555-007-9055-1","DOI":"10.1007\/s10555-007-9055-1"},{"key":"key-10.3934\/mbe.2023783-5","doi-asserted-by":"publisher","unstructured":"S. Chouaib, M. Z. Noman, K. Kosmatopoulos, M. A. Curran, Hypoxic stress: Obstacles and opportunities for innovative immunotherapy of cancer, <i>Oncogene<\/i>, <b>36<\/b> (2017), 439\u2013445. https:\/\/doi.org\/10.1038\/onc.2016.225","DOI":"10.1038\/onc.2016.225"},{"key":"key-10.3934\/mbe.2023783-6","doi-asserted-by":"publisher","unstructured":"C. R. Hong, B. D. Dickson, J. K. Jaiswal, F. B. Pruijn, F. W. Hunter, M. P. Hay, et al., Cellular pharmacology of evofosfamide (th-302): A critical re-evaluation of its bystander effects, <i>Biochem. Pharmacol.<\/i>, <b>156<\/b> (2018), 265\u2013280. https:\/\/doi.org\/10.1016\/j.bcp.2018.08.027","DOI":"10.1016\/j.bcp.2018.08.027"},{"key":"key-10.3934\/mbe.2023783-7","doi-asserted-by":"publisher","unstructured":"Z. Fu, A. M. Mowday, J. B. Smaill, I. F Hermans, A. V. Patterson, Tumour hypoxia-mediated immunosuppression: Mechanisms and therapeutic approaches to improve cancer immunotherapy, <i>Cells<\/i>, <b>10<\/b> (2021), 1006. https:\/\/doi.org\/10.3390\/cells10051006","DOI":"10.3390\/cells10051006"},{"key":"key-10.3934\/mbe.2023783-8","doi-asserted-by":"publisher","unstructured":"K. M. Reeves, P. N. Song, A. Angermeier, D. D. Manna, Y. F. Li, J. B. Wang, et al., 18f-fmiso pet imaging identifies hypoxia and immunosuppressive tumor microenvironments and guides targeted evofosfamide therapy in tumors refractory to pd-1 and ctla-4 inhibition, <i>Clin. Cancer Res.<\/i>, <b>28<\/b> (2022), 327\u2013337. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-2394","DOI":"10.1158\/1078-0432.CCR-21-2394"},{"key":"key-10.3934\/mbe.2023783-9","doi-asserted-by":"publisher","unstructured":"A. Hegde, P. Jayaprakash, C. A. Couillault, S. Piha-Paul, D. Karp, J. Rodon, et al., A phase i dose-escalation study to evaluate the safety and tolerability of evofosfamide in combination with ipilimumab in advanced solid malignanciesphase i study of evofosfamide and ipilimumab in solid tumors, <i>Clin. Cancer Res.<\/i>, <b>27<\/b> (2021), 3050\u20133060. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4118","DOI":"10.1158\/1078-0432.CCR-20-4118"},{"key":"key-10.3934\/mbe.2023783-10","doi-asserted-by":"publisher","unstructured":"L. Spiegelberg, S. J. van Hoof, R. Biemans, N. G. Lieuwes, D. Marcus, R. Niemans, et al., Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity, <i>Radiother. Oncol.<\/i>, <b>141<\/b> (2019), 247\u2013255. https:\/\/doi.org\/10.1016\/j.radonc.2019.06.034","DOI":"10.1016\/j.radonc.2019.06.034"},{"key":"key-10.3934\/mbe.2023783-11","doi-asserted-by":"publisher","unstructured":"T. Badar, D. R. Handisides, J. M. Benito, M. A. Richie, G. Borthakur, E. Jabbour, et al., Phase i study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia, <i>Am. J. Hematol.<\/i>, <b>91<\/b> (2016), 800\u2013805. https:\/\/doi.org\/10.1002\/ajh.24415","DOI":"10.1002\/ajh.24415"},{"key":"key-10.3934\/mbe.2023783-12","doi-asserted-by":"publisher","unstructured":"S. Kishimoto, J. R. Brender, G. V. R. Chandramouli, Y. Saida, K. Yamamoto, J. B. Mitchell, et al., Hypoxia-activated prodrug evofosfamide treatment in pancreatic ductal adenocarcinoma xenografts alters the tumor redox status to potentiate radiotherapy, <i>Antioxid. Redox Signal.<\/i>, <b>35<\/b> (2021), 904\u2013915. https:\/\/doi.org\/10.1089\/ars.2020.8131","DOI":"10.1089\/ars.2020.8131"},{"key":"key-10.3934\/mbe.2023783-13","doi-asserted-by":"publisher","unstructured":"J. P Laubach, C.-J. Liu, N. S. Raje, A. J. Yee, P. Armand, R. L. Schlossman, et al., A phase i\/ii study of evofosfamide, a hypoxia-activated prodrug with or without bortezomib in subjects with relapsed\/refractory multiple myelomaphase i\/ii study of evofosfamide in multiple myeloma, <i>Clin. Cancer Res.<\/i>, <b>25<\/b> (2019), 478\u2013486. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1325","DOI":"10.1158\/1078-0432.CCR-18-1325"},{"key":"key-10.3934\/mbe.2023783-14","doi-asserted-by":"publisher","unstructured":"A. J. Brenner, J. Floyd, L. Fichtel, J. Michalek, K. P. Kanakia, S. l. Huang, et al., Phase 2 trial of hypoxia activated evofosfamide (th302) for treatment of recurrent bevacizumab-refractory glioblastoma, <i>Sci. Rep.<\/i>, <b>11<\/b> (2021), 1\u20136. https:\/\/doi.org\/10.1038\/s41598-021-81841-0","DOI":"10.1038\/s41598-021-81841-0"},{"key":"key-10.3934\/mbe.2023783-15","doi-asserted-by":"publisher","unstructured":"P. Jayaprakash, M. Ai, A. Liu, P. Budhani, T. Bartkowiak, J. Sheng, et al., Targeted hypoxia reduction restores t cell infiltration and sensitizes prostate cancer to immunotherapy, <i>J. Clin. Invest.<\/i>, <b>128<\/b> (2018), 5137\u20135149. https:\/\/doi.org\/10.1172\/JCI96268","DOI":"10.1172\/JCI96268"},{"key":"key-10.3934\/mbe.2023783-16","unstructured":"E. Lopci, Pet radiopharmaceuticals for imaging of tumor hypoxia: A review of the evidence, <i>Am. J. Nucl. Med. Mol. Imaging<\/i>, <b>4<\/b> (2014), 365."},{"key":"key-10.3934\/mbe.2023783-17","doi-asserted-by":"publisher","unstructured":"S. Kumar, J. D. Sun, L. B. Zhang, R. B. Mokhtari, B. Wu, F. Y. Meng, et al., Hypoxia-targeting drug evofosfamide (th-302) enhances sunitinib activity in neuroblastoma xenograft models, <i>Transl. Oncol.<\/i>, <b>11<\/b> (2018), 911\u2013919. https:\/\/doi.org\/10.1016\/j.tranon.2018.05.004","DOI":"10.1016\/j.tranon.2018.05.004"},{"key":"key-10.3934\/mbe.2023783-18","doi-asserted-by":"publisher","unstructured":"C. Meaney, S. Rhebergen, M. Kohandel, In silico analysis of hypoxia activated prodrugs in combination with anti angiogenic therapy through nanocell delivery, <i>PLoS Computat. Biol.<\/i>, <b>16<\/b> (2020), e1007926. https:\/\/doi.org\/10.1371\/journal.pcbi.1007926","DOI":"10.1371\/journal.pcbi.1007926"},{"key":"key-10.3934\/mbe.2023783-19","doi-asserted-by":"publisher","unstructured":"D. Lindsay, C. M. Garvey, S. M. Mumenthaler, J. Foo, Leveraging hypoxia-activated prodrugs to prevent drug resistance in solid tumors, <i>PLoS Computat. Biol.<\/i>, <b>12<\/b> (2016), e1005077. https:\/\/doi.org\/10.1371\/journal.pcbi.1005077","DOI":"10.1371\/journal.pcbi.1005077"},{"key":"key-10.3934\/mbe.2023783-20","doi-asserted-by":"crossref","unstructured":"S. Hamis, M. Kohandel, M. Kohandel, L. J. Dubois, A. Yaromina, P. Lambin, et al., Combining hypoxia-activated prodrugs and radiotherapy in silico: Impact of treatment scheduling and the intra-tumoural oxygen landscape. <i>PLoS Computat. Biol.<\/i>, <b>16<\/b> (2020), e1008041. <ext-link ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.1371\/journal.pcbi.1008041\">https:\/\/doi.org\/10.1371\/journal.pcbi.1008041<\/ext-link>","DOI":"10.1371\/journal.pcbi.1008041"},{"key":"key-10.3934\/mbe.2023783-21","doi-asserted-by":"publisher","unstructured":"A. Saltelli, K. Aleksankina, W. Becker, P. Fennell, F. Ferretti, N. Holst, et al., Why so many published sensitivity analyses are false: A systematic review of sensitivity analysis practices, <i>Environ. Model. Softw.<\/i>, <b>114<\/b> (2019), 29\u201339. https:\/\/doi.org\/10.1016\/j.envsoft.2019.01.012","DOI":"10.1016\/j.envsoft.2019.01.012"},{"key":"key-10.3934\/mbe.2023783-22","doi-asserted-by":"crossref","unstructured":"A. Saltelli, <i>Global Sensitivity Analysis: The Primer<\/i>. Wiley, 2008.","DOI":"10.1002\/9780470725184"},{"key":"key-10.3934\/mbe.2023783-23","unstructured":"A. Saltelli, K. Chan, E. M. Scott, <i>Sensitivity Analysis<\/i>, Number no. 2008 in Wiley paperback series, (2009), Wiley."},{"key":"key-10.3934\/mbe.2023783-24","doi-asserted-by":"publisher","unstructured":"A. Saltelli, P. Annoni, I. Azzini, F. Campolongo, M. Ratto, S. Tarantola, Variance based sensitivity analysis of model output. design and estimator for the total sensitivity index, <i>Comp. Phys. Commun.<\/i>, <b>181<\/b> (2010), 259\u2013270. https:\/\/doi.org\/10.1016\/j.cpc.2009.09.018","DOI":"10.1016\/j.cpc.2009.09.018"},{"key":"key-10.3934\/mbe.2023783-25","doi-asserted-by":"publisher","unstructured":"M. J. W. Jansen, Analysis of variance designs for model output, <i>Comp. Phys. Commun.<\/i>, <b>117<\/b> (1989), 35\u201343. https:\/\/doi.org\/10.1016\/S0010-4655(98)00154-4","DOI":"10.1016\/S0010-4655(98)00154-4"},{"key":"key-10.3934\/mbe.2023783-26","unstructured":"J. C. Butcher, <i>The numerical analysis of ordinary differential equations: Runge-Kutta and general linear methods<\/i>, Wiley-Interscience, 1987."},{"key":"key-10.3934\/mbe.2023783-27","doi-asserted-by":"publisher","unstructured":"E. Prudencio, S. H. Cheung, Parallel adaptive multilevel sampling algorithms for the bayesian analysis of mathematical models, <i>Int. J. Uncertain. Quantif.<\/i>, <b>2<\/b> (2012). https:\/\/doi.org\/10.1615\/Int.J.UncertaintyQuantification.2011003499","DOI":"10.1615\/Int.J.UncertaintyQuantification.2011003499"},{"key":"key-10.3934\/mbe.2023783-28","doi-asserted-by":"publisher","unstructured":"G. O. Roberts, J. S. Rosenthal, General state space markov chains and mcmc algorithms. <i>Probab. Surv.<\/i>, <b>1<\/b> (2004), 20\u201371. https:\/\/doi.org\/10.1214\/154957804100000024","DOI":"10.1214\/154957804100000024"},{"key":"key-10.3934\/mbe.2023783-29","doi-asserted-by":"publisher","unstructured":"A. Gelman, D. B. Rubin, Inference from iterative simulation using multiple sequences. <i>Stat. Sci<\/i>, , <b>7<\/b> (1992), 457\u2013472. https:\/\/doi.org\/10.1214\/ss\/1177011136","DOI":"10.1214\/ss\/1177011136"},{"key":"key-10.3934\/mbe.2023783-30","unstructured":"Ernesto E Prudencio, Karl W Schulz. The parallel C++ statistical library 'QUESO': Quantification of Uncertainty for Estimation, Simulation and Optimization. In <i>Euro-Par 2011: Parallel Processing Workshops<\/i>, (2012), 398\u2013407, Springer. <ext-link ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.1007\/978-3-642-29737-3_44\">https:\/\/doi.org\/10.1007\/978-3-642-29737-3_44<\/ext-link>"},{"key":"key-10.3934\/mbe.2023783-31","doi-asserted-by":"publisher","unstructured":"P. Jayaprakash, P. D. A. Vignali, G. M. Delgoffe, M. A. Curran, Hypoxia reduction sensitizes refractory cancers to immunotherapy, <i>Annu. Rev. Med.<\/i>, <b>73<\/b> (2022), 251\u2013265. https:\/\/doi.org\/10.1146\/annurev-med-060619-022830","DOI":"10.1146\/annurev-med-060619-022830"},{"key":"key-10.3934\/mbe.2023783-32","doi-asserted-by":"publisher","unstructured":"E. A. B. F. Lima, D. Faghihi, R. Philley, J. C. Yang, J. Virostko, C. M. Phillips, et al., Bayesian calibration of a stochastic, multiscale agent-based model for predicting in vitro tumor growth, <i>PLoS Computat. Biol.<\/i>, <b>17<\/b> (2021), e1008845. https:\/\/doi.org\/10.1371\/journal.pcbi.1008845","DOI":"10.1371\/journal.pcbi.1008845"},{"key":"key-10.3934\/mbe.2023783-33","doi-asserted-by":"publisher","unstructured":"C. M Phillips, E. A. B. F. Lima, R. T. Woodall, A. Brock, T. E. Yankeelov, A hybrid model of tumor growth and angiogenesis: In silico experiments, <i>Plos One<\/i>, <b>15<\/b> (2020), e0231137. https:\/\/doi.org\/10.1371\/journal.pone.0231137","DOI":"10.1371\/journal.pone.0231137"},{"key":"key-10.3934\/mbe.2023783-34","doi-asserted-by":"publisher","unstructured":"E. A. B. F. Lima, J. T. Oden, D. A. Hormuth, T. E. Yankeelov, R. C. Almeida, Selection, calibration, and validation of models of tumor growth, <i>Math.Models Methods Appl. Sci.<\/i>, <b>26<\/b> (2016), 2341\u20132368. https:\/\/doi.org\/10.1142\/S021820251650055X","DOI":"10.1142\/S021820251650055X"},{"key":"key-10.3934\/mbe.2023783-35","doi-asserted-by":"publisher","unstructured":"E. A. B. F. Lima, R. A. F. Wyde, A. G. Sorace, T. E. Yankeelov, Optimizing combination therapy in a murine model of her2+ breast cancer, <i>Comput. Methods Appl. Mech. Eng.<\/i>, <b>402<\/b> (2022), 115484. https:\/\/doi.org\/10.1016\/j.cma.2022.115484","DOI":"10.1016\/j.cma.2022.115484"},{"key":"key-10.3934\/mbe.2023783-36","doi-asserted-by":"publisher","unstructured":"T. E. Yankeelov, J. C. Gore, Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples, <i>Curr. Med. Imaging<\/i>, <b>3<\/b> (2007), 91\u2013107. https:\/\/doi.org\/10.2174\/157340507780619179","DOI":"10.2174\/157340507780619179"},{"key":"key-10.3934\/mbe.2023783-37","doi-asserted-by":"publisher","unstructured":"G. Lestini, F. Mentr\u00e9, P. Magni, Optimal design for informative protocols in xenograft tumor growth inhibition experiments in mice, <i>AAPS J.<\/i>, <b>18<\/b> (2016), 1233\u20131243. https:\/\/doi.org\/10.1208\/s12248-016-9924-z","DOI":"10.1208\/s12248-016-9924-z"},{"key":"key-10.3934\/mbe.2023783-38","unstructured":"S. D. C\u00e1rdenas, C. J. Reznik, R. Ranaweera, F. F. Song, C. H. Chung, E. J. Fertig, et al., Model-informed experimental design recommendations for distinguishing intrinsic and acquired targeted therapeutic resistance in head and neck cancer. <i>npj Syst. Biol. Appl.<\/i>, <b>8<\/b> (2022), 32. <ext-link ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.1038\/s41540-022-00244-7\">https:\/\/doi.org\/10.1038\/s41540-022-00244-7<\/ext-link>"},{"key":"key-10.3934\/mbe.2023783-39","doi-asserted-by":"publisher","unstructured":"S. Bandara, J. P. Schl\u00f6der, R. Eils, H. G. Bock, T. Meyer, Optimal experimental design for parameter estimation of a cell signaling model, <i>PLoS Computat. Biol.<\/i>, <b>5<\/b> (2009), e1000558. https:\/\/doi.org\/10.1371\/journal.pcbi.1000558","DOI":"10.1371\/journal.pcbi.1000558"},{"key":"key-10.3934\/mbe.2023783-40","doi-asserted-by":"publisher","unstructured":"H. W. Wang, C. Zhao, C. A. Santa-Maria, L. A. Emens, A. S. Popel, Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer, <i>iScience<\/i>, <b>25<\/b> (2022). https:\/\/doi.org\/10.1016\/j.isci.2022.104702","DOI":"10.1016\/j.isci.2022.104702"},{"key":"key-10.3934\/mbe.2023783-41","doi-asserted-by":"publisher","unstructured":"P. Saxena, S. Gambhir, M. Dixit, Insight into tumor hypoxia: Radionuclide-based biomarker as diagnostic tools, <i>Curr. Top. Med. Chem.<\/i>, <b>23<\/b> (2023), 1136\u20131154. https:\/\/doi.org\/10.2174\/1568026623666230515154442","DOI":"10.2174\/1568026623666230515154442"}],"container-title":["Mathematical Biosciences and Engineering"],"original-title":[],"link":[{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2023783?viewType=html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T01:37:20Z","timestamp":1739237840000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimspress.com\/article\/doi\/10.3934\/mbe.2023783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3934\/mbe.2023783","relation":{},"ISSN":["1551-0018"],"issn-type":[{"value":"1551-0018","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}